$CURR CURE Pharmaceutical Expands to Europe, Signs

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
167
$CURR CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

CURE debuts “CUREinside” quality mark on the packaging of ReLeaf Europe’s sublingual tinctures and new topical cream product lines


OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products. The agreement grants ReLeaf Europe exclusive access to CURE’s encapsulation technology for certain oral and topical cannabis products in the Netherlands, the world’s first medical cannabis market. ReLeaf Europe products will be the first to use the CUREinside™ quality mark to bolster consumer confidence.

According to market research, Europe is one of the world’s largest medical cannabis markets due to various governments’ approval for medicinal purposes.

“ReLeaf Europe is one of the few pharmacy providers of pharmaceutical-grade medicinal cannabis oils in Europe and an ideal partner for our first step into the European market because of its commitment to establishing clinical evidence and following EU GMP and GDP standards,” said Jessica Rousset, COO of CURE. “Through this agreement, we will roll out our powered by CURE strategy that includes exclusive licensing relationships to build global market share.”

ReLeaf Europe is tackling the largest market in the world for cannabis by establishing a foothold in Holland – a market estimated to reach $2.6B by 2028 – and by pursuing innovative delivery systems and distribution networks.

“We are standard-bearers in clinical cannabis care in Europe and CURE shares our values in its science and manufacturing practices in seeking the highest of quality standards,” said Jesse Kuijper, CEO of ReLeaf Europe. “This collaboration will help accelerate our market presence through highly differentiated products.”

CURE will power several ReLeaf Europe products, including one sublingual tincture and two topical creams to be launched in 2020.

About CURE Pharmaceutical
CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has an FDA- and DEA- registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform™ includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system. CUREform's combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.

About ReLeaf Europe

ReLeaf Europe bv is active since 2017 in the European pharmaceutical market. All products are distributed through licensed pharmacies, OTC as well as prescripted. Clinical Cannabis Care bv is a compounding pharmacy based in the Netherlands producing cannabis products for delivery direct to patients or through pharmacies. Cannadis Europe bv is developing EU-GMP THC and CBD API’s (Active Pharmaceutical Ingredients) for pharmacists in Europe as well API’s for scientific research studies to be launched in 2020. Both Clinical Cannabis Care bv and Cannadis Europe bv are part of ReLeaf Europe bv.

For more information about CURE Pharmaceutical, please visit its website at www.curepharma.com.

Media Contact:
Paulo Acuna
pacuna@olmsteadwilliams.com310-824-9000


Source: Cure Pharmaceutical Holding Corp.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UnitedHealth’s CMS Audit Shock Puts Disclosures Under Lens

Updated Category News Views 123

Medicare Advantage's audit bill just landed with a nasty thud. UnitedHealth Group shares fell more than 10% on November 18 after the Centers for Medicare & Medicaid Services proposed new anti-fraud, audit, and repayment rules for the program. For holders of NYSE:UNH, this was not some sleepy policy memo buried in a federal filing cabinet. It was a hard reminder that...

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 65

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 81

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
Mindgruve's Tech Hire Puts Sightline Growth in Focus

Updated Category News Views 67

Agency technology hires usually land with all the thunder of a stapler dropping, but this one deserves a closer look. Mindgruve has named Steve Terjeson vice president of technology, handing a former WPP Choreograph executive the job of leading its software development and data engineering teams. The assignment is not vague: push AI innovation, make the proprietary...

Continue Reading
Saban Center Partnership Gives Health Learning a Lift

Updated Category News Views 118

A dinosaur race may sound like pure kid bait, but the underlying idea is sturdier than that. Cardiac Solutions and the Seale family are backing an interactive health-and-performance exhibit at Tuscaloosa’s planned Saban Center, a project intended to turn questions about movement, fitness, heart rate and oxygen levels into something children can actually touch, test and...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 55

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 155

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 120

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 17

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading

Top 5 Most Recently Viewed Articles

ELITE Solar Achieves Gold Rating for Exceptional Sustainability

Updated Category News Views 105

ELITE Solar Earns Prestigious EcoVadis Gold Medal ELITE Solar, a renowned global manufacturer in the solar industry, proudly announces its latest achievement: the EcoVadis Gold Medal for sustainability performance. This esteemed recognition places the company among the top 5% of organizations worldwide evaluated by EcoVadis, a well-respected platform known for its...

Continue Reading
Zelluna ASA's New Share Issuance for Strategic Development

Updated Category News Views 429

Introduction to Zelluna ASA's Share Issuance Zelluna ASA has taken a significant step forward by announcing the issuance of new shares. This move has been orchestrated through a resolution made by the Company's Annual General Meeting. The decision allows the Board of Directors to issue shares, each priced at NOK 26. The primary goal is to settle an option exercise fee...

Continue Reading
Nokia's Strategic Share Buyback: Insights and Impact

Updated Category News Views 90

Nokia's Recent Share Repurchase Initiative Nokia Corporation, a transformative technology leader, recently took significant steps in its financial strategy by executing a share buyback program. This move aims not only to strengthen the company's market position but also to return approximately EUR 600 million in cash to its shareholders over a defined period....

Continue Reading
Berman Tabacco Expands Legal Action Against Outset Medical, Inc.

Updated Category News Views 176

Berman Tabacco Expands Legal Action Against Outset Medical, Inc. Berman Tabacco is making headlines with a significant development in its legal efforts concerning Outset Medical, Inc. This new class action complaint has been lodged in the United States District Court for the Northern District of California against Outset Medical, Inc. (NASDAQ: OM) and specific current and...

Continue Reading
New York City Rental Surge: Bronx Hits Over 61% Increase

Updated Category News Views 304

NYC Rental Prices Surge Significantly Newly released data highlights a troubling trend as rental prices in New York City continue to rise sharply, now impacting the affordability of living for many residents. The Bronx has reported a staggering rent increase of over 61% since the last six years, marking it as the borough with the steepest rise in rental costs. Current...

Continue Reading